Medical Innovation Versus Stem Cell Tourism

  title={Medical Innovation Versus Stem Cell Tourism},
  author={Olle Lindvall and Insoo Hyun},
  pages={1664 - 1665}
Stem cell tourism is criticized on grounds of consumer fraud, blatant lack of scientific justification, and patient safety. However, the issues are complex because they invoke questions concerning the limits of acceptable medical innovation and medical travel. Here we discuss these issues and articulate conditions under which “unproven” therapies may be offered to patients outside of regular clinical trials. 

Stem cell tourism and Canadian family physicians.

The provision of unproven stem cell–based treatments by clinics in countries around the world—a phenomenon that has been called stem cell tourism —is a growing trend with implications for both the

Stem‐cell tourism and scientific responsibility

Stem-cell tourism exploits the hope of patients desperate for therapies and cures to exploit the promise of stem-cell-based treatments.

Stem Cell Tourism and Doctors' Duties to Minors—A View From Canada

This paper considers what duties physicians may have toward minor patients whose parents/guardians wish to engage in stem cell tourism on their behalf and uses the Canadian perspective to address the broadly relevant issues raised by this trend.

[Bioethical challenges of stem cell tourism].

The media has raised unfounded expectations in patients and the public about the real clinical benefits of stem cells, and the number of unregulated clinics is increasing around the world, making direct offers through Internet of unproven stem cell therapies that attract desperate patients that have not found solutions in standard medicine.

What's Missing? Discussing Stem Cell Translational Research in Educational Information on Stem Cell “Tourism”

Patients and the public have several reasons for seeking stem cell-based interventions for many different diseases and conditions, and a perception that their home country has a burdensome or sluggish regulatory system for the approval of novel stem cell therapies may contribute to a certain sense of distrust of regulatory agencies governing the conduct of clinical research.

Stem cell stratagems in alternative medicine.

  • D. Sipp
  • Medicine
    Regenerative medicine
  • 2011
The contours of the stem cell industry as practiced by alternative medicine providers are surveyed, and points of commonality in their strategies for marketing are highlighted.

Safeguarding patients against stem cell tourism.

The media frenzy surrounding the case of Dr Trossel and his dismissal following his controversial advice, and offer of unregulated stem cell treatment to a multiple sclerosis patient, led the General Medical Council to conclude he had breached medical practice by ‘exploiting vulnerable patients’.

Stem cell tourism

The aim of this chapter is to provide an overarching review of existing data and theoretical work in the stem cell research field, and assist with identifying issues requiring further attention and research.



ISSCR Guidelines for the Clinical Translation of Stem Cells.

This appendix provides a summary of and links to the ISSCR Guidelines for the Clinical Translation of Stem Cells and supporting documents.

Ethics and innovation in medicine

  • G. Agich
  • Medicine
    Journal of medical ethics
  • 2001
The regulatory ethics paradigm creates a presumption that innovations that are not rigorously validated are ethically dubious, and requires the preparation of investigational protocols according to sound evidentiary and methodological standards.

Research versus Innovation: Real Differences

  • H. Morreim
  • Medicine
    The American journal of bioethics : AJOB
  • 2005
This essay focuses on the claim that the distinction between research and innovation is untenable, and the proposal that virtually any research that is acceptable for competent people to choose to enter is equally acceptable for surrogate enrollment of an incompetent person.

Donor-Derived Brain Tumor Following Neural Stem Cell Transplantation in an Ataxia Telangiectasia Patient

The findings here suggest that neuronal stem/progenitor cells may be involved in gliomagenesis and provide the first example of a donor-derived brain tumor complicating neural stem cell therapy.

When is surgery research? Towards an operational definition of human research

  • C. Margo
  • Medicine
    Journal of medical ethics
  • 2001
Enforcing more rigid and less ambiguous guidelines of human research may curtail enrolment into some studies, but it will also protect patients from being used as subjects without their knowledge.

Ethics and Innovation

Using the familiar insight that principals and agents can jointly gain by reducing agency costs, this essay argues (1) that lawyers hoping to attract clients should seek to improve the quality of

Transplantation of liver grafts from living donors into adults--too much, too soon.

Since 1995, many liver-transplantation programs in the United States,1,2 Europe,3 and Asia4,5 have performed adult-to-adult transplantation of liver grafts from living donors. Since 1997, more than